
Study Sheds Light on Genetic Factors for Intracranial Aneurysm
CINCINNATIA large collaborative study that included researchers from the University of Cincinnati (UC) College of Medicine is reporting a new chromosomal region associated with intracranial aneurysm susceptibility, shedding new light on genetic risk factors for a life-threatening condition.
The research from the Familial Intracranial Aneurysm (FIA) project is being presented today (Thursday, Feb. 13, 2014), at the American Heart Association/American Stroke Associations International Stroke Conference 2014 in San Diego.
Joseph Broderick, MD, distinguished research professor at UC and director of the UC Neuroscience Institute, an institute of the UC College of Medicine and UC Health, is giving the oral presentation on behalf of an international collaborative research effort. Sponsored by the National Institute of Neurological Diseases and Stroke (NINDS), the study is examining genetic and environmental risk factors for intracranial aneurysm. This analysis involved collaboration with researchers in the Netherlands and Finland.
An intracranial aneurysm is a weak, bulging spot on the wall of a brain artery. The aneurysm may eventually rupture, allowing blood to escape into the area around the brain (subarachnoid hemorrhage). When that happens, advanced surgical treatment is often required. Treatment options include surgical clipping, coiling and bypass.
Unruptured brain aneurysms often have no symptoms. The Brain Aneurysm Foundation estimates that 6 million Americans have an unruptured brain aneurysm that has gone undiagnosed. When an aneurysm does rupture, the foundation says, about 15 percent of the victims die before reaching a hospital. Ruptured brain aneurysms are fatal in about 30 to 40 percent of cases. Of those who survive, about 66 percent suffer some permanent neurological defect.
The researchers, by performing a genomewide association analysis in a discovery sample of Caucasian ancestry, identified evidence of association of intracranial aneurysms with a region of chromosome 7, one of 23 chromosome pairs in the human body. Additionally, they replicated evidence of association with IA in chromosome 9, which was reported previously to be associated with IA.
"The chromosome 7 region, while newly associated with intracranial aneurysm, was previously associated with ischemic stroke and large vessel ischemic stroke, suggesting a possible genetic and vascular link between these stroke subtypes and intracranial aneurysm, says Broderick.
"As for chromosome 9, weve reconfirmed that its the location of the area most strongly associated with intracranial aneurysm. This region on chromosome 9 has also been linked to ischemic stroke related to large artery disease.
Broderick notes that its important to gain a better and more complete understanding of the gene variations that lead to aneurysm.
"If we identify people who have a stronger family risk for aneurysm, we can make it very clear to them that they must avoid other risk factors such as smoking and high blood pressure, he says.
Also, he said, people with an elevated genetic risk factor might be encouraged to undergo brain imaging to make sure no aneurysms are developing.
Related Stories
Ohio could soon make breast cancer screenings more affordable
May 9, 2025
The University of Cincinnati Cancer Center's Ann Brown was featured in Local 12 and Cincinnati Enquirer reports on a bill introduced by Rep. Jean Schmidt in the Ohio legislature that seeks to eliminate out of pocket medical expenses such as copays and deductibles associated with supplemental breast cancer screenings.
Preparing students for artificial intelligence in education
May 8, 2025
Laurah Turner, PhD, associate dean for artificial intelligence and educational informatics at the University of Cincinnati's College of Medicine, recently joined the For The Love of EdTech podcast to discuss the usage of personalized learning and AI coaches to enhance educational experiences.
UC lab-on-a-chip devices take public health into home
May 8, 2025
University of Cincinnati engineers created a new device to help doctors diagnose depression and anxiety. The “lab-on-a-chip” device measures the stress hormone cortisol from a patient’s saliva. Knowing if a patient has elevated stress hormones can provide useful diagnostic information even if patients do not report feelings of anxiety, stress or depression in a standard mental health questionnaire.